Platycodon D protects human nasal epithelial cells from pyroptosis through the Nrf2/HO-1/ROS signaling cascade in chronic rhinosinusitis

被引:0
|
作者
Ruizhi Wang
Yongchun Wang
He Liu
Jinxiang Zhu
Caishan Fang
Weizhen Xu
Zesheng Lu
Yajie Yan
Weiping He
Yan Ruan
Min Zhou
机构
[1] The First Clinical Medical School of Guangzhou University of Chinese Medicine,Department of Otolaryngology Head and Neck Surgery
[2] The First Affiliated Hospital of Guangzhou University of Chinese Medicine,Department of Allergy
[3] Guangdong Clinical Research Academy of Chinese Medicine,undefined
[4] The Third Affiliated Hospital of Sun Yat-Sen University,undefined
[5] Hospital of Chengdu University of Traditional Chinese Medicine,undefined
[6] Chengdu University of Traditional Chinese Medicine,undefined
来源
关键词
Pyroptosis; Chronic rhinosinusitis; Platycodon D; NLRP3 inflammasome; Nrf2/HO-1 antioxidant signaling pathway;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Huachansu Injection induces ferroptosis in multiple myeloma through NRF2/HO-1 signaling pathway
    Yang, Jing
    Wang, Fengnan
    Hu, Zhongxiao
    Liu, Xixi
    Zhang, Weiguang
    Li, Chencheng
    Wang, Wanxia
    Reaila, Jianati
    Zhang, Xiaoli
    Zhu, Guangrong
    Tian, Fang
    Chen, Biqing
    Zhu, Xuejun
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 343
  • [42] Curcumin activates Nrf2/HO-1 signaling to relieve diabetic cardiomyopathy injury by reducing ROS in vitro and in vivo
    Wu, Xia
    Zhou, Xueliang
    Lai, Songqing
    Liu, Jichun
    Qi, Jianwei
    FASEB JOURNAL, 2022, 36 (09):
  • [43] Morroniside protects HT-22 cells against oxygen-glucose deprivation/reperfusion through activating the Nrf2/HO-1 signaling pathway
    Zhang, Lan
    Wang, Huiping
    Liu, Yan
    Wang, Li
    Pan, Weikang
    Yuan, Bo
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2022, 42 (01) : 9 - 15
  • [44] Choline Protects the Heart from Doxorubicin-Induced Cardiotoxicity through Vagal Activation and Nrf2/HO-1 Pathway
    Guo, Fuding
    Wang, Yueyi
    Wang, Jun
    Liu, Zhihao
    Lai, Yanqiu
    Zhou, Zhen
    Liu, Zihan
    Zhou, Yuyang
    Xu, Xiao
    Li, Zeyan
    Wang, Meng
    Yu, Fu
    Hu, Ruijie
    Zhou, Liping
    Jiang, Hong
    Oxidative Medicine and Cellular Longevity, 2022, 2022
  • [45] Choline Protects the Heart from Doxorubicin-Induced Cardiotoxicity through Vagal Activation and Nrf2/HO-1 Pathway
    Guo, Fuding
    Wang, Yueyi
    Wang, Jun
    Liu, Zhihao
    Lai, Yanqiu
    Zhou, Zhen
    Liu, Zihan
    Zhou, Yuyang
    Xu, Xiao
    Li, Zeyan
    Wang, Meng
    Yu, Fu
    Hu, Ruijie
    Zhou, Liping
    Jiang, Hong
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [46] Oral administration of proniosomal glibenclamide formulation protects testicular tissue from hyperglycemia fluctuations and ROS via Nrf2/HO-1 pathway
    Alyami, Nouf M.
    Alnakhli, Zainab A.
    Alshiban, Noura M.
    Maodaa, Saleh
    Almuhaini, Ghufran A.
    Almeer, Rafa
    Alshora, Doaa
    Ibrahim, Mohamed
    HELIYON, 2024, 10 (10)
  • [47] NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells
    Pecorelli, Alessandra
    Bocci, Velio
    Acquaviva, Alessandra
    Belmonte, Giuseppe
    Gardi, Concetta
    Virgili, Fabio
    Ciccoli, Lucia
    Valacchi, Giuseppe
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2013, 267 (01) : 30 - 40
  • [48] Erastin induces ferroptosis in cervical cancer cells via Nrf2/HO-1 signaling pathway
    Wei, Xiaoning
    Huang, Qiaoqiao
    Huang, Jinbing
    Yu, Li
    Chen, Junying
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2023, 37
  • [49] Norcantharidin induces ferroptosis via the suppression of NRF2/HO-1 signaling in ovarian cancer cells
    Zhu, Xiaoyan
    Chen, Xiaohong
    Qiu, Longshan
    Zhu, Jianhua
    Wang, Jiancai
    ONCOLOGY LETTERS, 2022, 24 (04)
  • [50] Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells
    Jing, Shangwen
    Lu, Yantong
    Zhang, Jing
    Ren, Yan
    Mo, Yousheng
    Liu, Dongdong
    Duan, Lining
    Yuan, Zhongyu
    Wang, Changjun
    Wang, Qi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 2981 - 2993